Related Topics News -

     
 Title only   |   Print    Next page > 
     
《業績》醫脈通全年純利3.34億元人幣升6% 息14.35分人幣

2026-03-26T  
《大行》大華繼顯首予醫脈通「買入」評級 目標價13.5元

2026-02-25T  
《大行》匯豐升醫脈通目標價至14元 業務執行保持正軌

2025-08-27T  
《業績》醫脈通半年純利1.55億人幣升5.9% 中期息降至11.66分人幣

2025-08-25T  
《大行》匯豐研究升醫脈通目標價至13.5元 評級降至「持有」

2025-03-26T  
《業績》醫脈通全年純利3.15億人民幣增30% 末期息派13.66分

2025-03-24T  
《大行》里昂:中國互聯網醫療保健行業乘著AI浪潮

2025-02-17T  
*里昂:中國互聯網醫療保健行業乘著AI浪潮

2025-02-17T  
《業績》醫脈通半年純利1.47億元人民幣升48.6% 中期息12.05分人民幣

2024-08-27T  
醫脈通與NCCN達成癌症護理戰略合作

2024-07-30T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.